Edwards Lifesciences Corp

NYSE:EW   12:03:52 AM EDT
+1.81 (+2.22%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)51.49B
Current PE33.84
Forward PE 33.18
2yr Forward PE 29.22
See more stats
Estimates Current Quarter
Revenue$1.39 Billion
Adjusted EPS$0.61
See more estimates
10-Day MA$79.15
50-Day MA$76.04
200-Day MA$89.05
See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

One Edwards Way, Irvine, California 92614
United States of America
Phone: +1.949.250.2500
Number of Employees: 15700


Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring systems measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.